Evidence map›Paper›PMID 39263451›Full record

ArticleRoyal Society open science2024

An ensemble approach integrating LSTM and ARIMA models for enhanced financial market predictions.

Lesia Mochurad, Andrii Dereviannyi

Abstract read
In one paragraph

Article in Royal Society open science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lesia MochuradDepartment of Artificial Intelligence, Lviv Polytechnic National University, Kniazia Romana str., 5, Lviv 79905, Ukraine.ORCID https://orcid.org/0000-0002-4957-1512
Andrii DereviannyiDepartment of Artificial Intelligence, Lviv Polytechnic National University, Kniazia Romana str., 5, Lviv 79905, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Forecasting financial markets is a complex task that requires addressing various challenges, such as market complexity, data heterogeneity, the need for rapid response and constant changes in conditions, to gain a competitive advantage. To effectively address these challenges, it is necessary to constantly improve existing and develop new methods of intelligent forecasting, which will improve the accuracy of forecasts, reduce risks and increase the productivity of financial decision-making processes. In this article, we study and analyse forecasting methods in financial markets, such as support vector regression (SVR), autoregressive integrated moving average (ARIMA), long short-term memory recurrent neural network (LSTM) and extreme gradient boosting algorithm (XG-Boost). Based on this analysis, we propose an ensemble forecasting procedure that integrates LSTM and ARIMA models. Due to the careful combination of these models, our approach yields better results than individual methods. For example, our model demonstrates a significant 15% improvement in root mean square error (RMSE) and a slight improvement in coefficient of determination compared with LSTM. Furthermore, simulation results obtained on three real-world datasets and evaluated using the RMSE criterion confirm the superiority of our proposed method over alternative methods such as LSTMs, transformer models and optimized deep recurrent neural networks with long short-term memory for financial market forecasting. Furthermore, our approach creates the prerequisites for parallelizing both models, thus providing an opportunity to accelerate forecasting results in future research.

Indexed as

ensemble learningfinancial marketsforecastingmachine learningneural networks

Identifiers

PMID39263451
PMCPMC11387057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.